Drugs / Greenplast
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT05645198 Comparator | Oct 2022 → Dec 2024 | gastric neoplasm | Bucheon St. Mary's Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Greenplast | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05645198 ↗ |
| Route | Topical | “Directly apply Greenplast (Aprotinin 1000kIU/mL, Thrombin 500IU/mL, Fibrinogen 95mg/mL) 4 gram evenly at the suprapancreatic surgical bed after gastrectomy” NCT05645198 ↗ |